12-aminopyridazinopyrroloisoquinoline compounds
US5614516A · kind A · utility
1Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 1995 |
| Grant date | Mar 25, 1997 |
| Priority date | — |
| Expiry date | Feb 7, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to new 12-amino-pyridazino-[4',5':3,4]-pyrrolo[2,1-a]isoquinolines of general formula (I) ##STR1## wherein --NR.sub.1 R.sub.2 represents an amino or substituted amino group, and acid addition salts thereof. The new active substances have potential use in pharmaceutical compositions for treating cardiac insufficiency and cerebral metabolic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.